Literature DB >> 19882328

Hepatocellular carcinoma infiltrated with non-Hodgkin's lymphoma: report of a case.

Tohru Utsunomiya1, Masahiro Okamoto, Eiji Tsujita, Manabu Yamamoto, Shinichi Tsutsui, Megumu Fujihara, Teruyoshi Ishida.   

Abstract

A 70-year-old woman diagnosed to have a hepatitis C virus (HCV) infection was referred to our hospital because of a solitary liver tumor. because of a solitary liver tumor. She underwent a partial hepatectomy, and the tumor was histologically diagnosed as a hepatocellular carcinoma (HCC). diagnosed as a hepatocellular carcinoma (HCC). In addition, a focal follicle consisting of atypical lymphoid cells was seen within the HCC. cells was seen within the HCC. Two months later, she was readmitted because of weakness and rapidly developing abdominal fullness. developing abdominal fullness. An abdominal computed tomography scan showed widespread tumors with ascites. with ascites. A cytological examination of the ascites showed large-sized atypical lymphoid cells. showed large-sized atypical lymphoid cells. An immunohistochemical stain confirmed that the atypical lymphoid cells within the HCC were positive for the CD 20 antigen. antigen. Taking these findings into account, the hepatic tumor was determined to be a HCC infiltrated with diffuse large B-cell lymphoma. diffuse large B-cell lymphoma. The coexistence of HCC and non-Hodgkin's lymphoma (NHL) is extremely rare. and non-Hodgkin's lymphoma (NHL) is extremely rare. We herein report a case of HCC infiltrated with NHL. We herein report a case of HCC infiltrated with NHL.

Entities:  

Mesh:

Year:  2009        PMID: 19882328     DOI: 10.1007/s00595-009-3966-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Co-occurrence of hepatocellular carcinoma and lymphoma in patients with hepatitis C virus cirrhosis.

Authors:  M Y Shapira; M Muszkat; I Braunstein; I Gotsman
Journal:  J Clin Gastroenterol       Date:  2001-04       Impact factor: 3.062

2.  Coexistence of splenic non-Hodgkin's lymphoma with hepatocellular carcinoma in a patient with chronic hepatitis C.

Authors:  Takashi Himoto; Yoshiaki Miyauchi; Kei Nomura; Toshiaki Fushitani; Kazutaka Kurokohchi; Tsutomu Masaki; Akihiro Deguchi; Seiji Nakai; Toshiharu Funaki; Seishiro Watanabe; Reiji Haba; Shigeki Kuriyama
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

3.  Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.

Authors:  Caroline Besson; Danielle Canioni; Eric Lepage; Stanislas Pol; Pierre Morel; Pierre Lederlin; Achiel Van Hoof; Hervé Tilly; Philippe Gaulard; Bertrand Coiffier; Christian Gisselbrecht; Nicole Brousse; Félix Reyes; Olivier Hermine
Journal:  J Clin Oncol       Date:  2006-01-17       Impact factor: 44.544

4.  The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.

Authors:  E R Quinn; C H Chan; K G Hadlock; S K Foung; M Flint; S Levy
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

5.  Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia.

Authors:  Tatsuki R Kataoka; Yoshitane Tsukamoto; Naoko Kanazawa; Tadahiro Izumi; Nobuhisa Awata; Yasuko Nishizawa; Masahiko Ohsawa; Shingo Ishiguro
Journal:  Pathol Int       Date:  2006-05       Impact factor: 2.534

6.  Hepatitis C infection and risk of malignant lymphoma.

Authors:  Claudia Schöllkopf; Karin Ekström Smedby; Henrik Hjalgrim; Klaus Rostgaard; Inge Panum; Lasse Vinner; Ellen T Chang; Bengt Glimelius; Anna Porwit; Christer Sundström; Mads Hansen; Hans-Olov Adami; Mads Melbye
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

7.  Renal cell carcinoma with non-Hodgkin's lymphoma infiltration: a case report.

Authors:  Yurdanur Sullu; Gamze Donmez; Bedri Kandemir; Seda Gun
Journal:  Pathol Res Pract       Date:  2007-07-26       Impact factor: 3.250

8.  Renal cell cancer: best recipient of tumor-to-tumor metastasis.

Authors:  A Sella; J Y Ro
Journal:  Urology       Date:  1987-07       Impact factor: 2.649

9.  Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.

Authors:  Amy Lin; Jaydeep S Kadam; Henry C Bodenheimer; John Leonard; Maureen A Joyce; Gerond Lake-Bakaar
Journal:  J Med Virol       Date:  2008-08       Impact factor: 2.327

10.  Diffuse large B-cell lymphoma in the ampulla of vater causing obstructive jaundice: report of a case.

Authors:  Naru Kondo; Hiroshi Furuya; Shigeru Yamamoto; Akinobu Nakano; Yoshihiro Sakashita
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

  10 in total
  5 in total

1.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.

Authors:  Hirotada Tajiri; Keishi Sugimachi; Nao Kinjo; Masahiko Ikebe; Junko Tanaka; Kiyoshi Tanaka; Shuichi Tsukamoto; Shinsuke Mii; Eiji Kajiwara; Tatsuro Shimokama; Hidefumi Higashi
Journal:  Surg Today       Date:  2013-02-13       Impact factor: 2.549

3.  Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.

Authors:  Mu-Hsien Lee; Yu-Ching Lin; Hao-Tsai Cheng; Wen-Yu Chuang; Hsin-Chih Huang; Hsiao-Wen Kao
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

4.  Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.

Authors:  Kui Chen; Sharif Ahmed; Oyedele Adeyi; John E Dick; Anand Ghanekar
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

5.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.